Medicine by Design brings together more than 130 leading researchers at the University of Toronto and its affiliated hospitals at the convergence of science, engineering and medicine to advance regenerative medicine discoveries and dramatically improve health outcomes. Created in 2015 with an unprecedented $114-million investment from the federal government’s Canada First Research Excellence Fund, Medicine by Design marks a new chapter in Toronto’s long history of global excellence in regenerative medicine, positioning Canada to continue to lead the field for decades to come.
External link for Medicine by Design - University of Toronto
661 University Ave
1002
Toronto, Ontario M5G 1M1, CA
Great news for cell and gene therapies and for patients 👏
We’re thrilled to announce Poseida entered into a definitive agreement to be acquired by Roche Holdings, Inc. At the closing of the proposed transaction, Poseida and its employees will join the Roche Group and advance our innovative pipeline of non-viral, Tscm-rich CAR-T therapies and genetic medicines as part of Roche’s Pharmaceuticals Division. Details here: https://lnkd.in/gvbwFU7r #CapacitytoCure #celltherapy #CART #geneticmedicines
Last chance to register for the #MbDSymposium taking place on Dec. 9th. Registration closes this Friday. Save your spot today! Learn more and register here: https://lnkd.in/gGZwizpG
Getting underway at the Building a Biotech Venture information session with Molly Shoichet from PRiME Next-Generation Precision Medicine at the University of Toronto and Allison Brown from #MedicinebyDesign. Couldn't come to the session today? Find more details about the program and how to apply here: https://lnkd.in/g-NgbbUR.
The Building a Biotech Venture program info session is this Thursday! Are you part of a #regenmed or #PrecisionMedicine research lab at #UofT or its affiliated hospitals? Are you thinking about taking your first steps toward entrepreneurship? Join us on November 21 for an information session on the Building a Biotech Venture program. Learn more and register here: https://lnkd.in/g-NgbbUR
Congrats Kristin Hope and all new and continuing Canada Research Chairs! #MedicinebyDesign #NewInvestigator Read about Dr. Hope's recruitment to Toronto ➡ https://lnkd.in/eRKvA6Q5
Congratulations to UHN researchers Dr. Kristin Hope from the Princess Margaret Cancer Centre and Dr. Jennifer Campos from the KITE Research Institute on their new Canada Research Chair funding! This funding will go toward their research on understanding #leukemia #StemCells and #aging and #sensory impairments. Read more about how these researchers are leading innovation in their fields! ➡️ https://lnkd.in/gU3JC_-7
Looking forward to the next session!
Join us for SCN and Medicine by Design - University of Toronto's Careers Beyond Academia session on November 20. Hear from Dr. Kevin Robb from STEMCELL Technologies and Dr. Danielle Spice from Stealth Mode Biotech as they discuss career paths in big companies vs. startups, securing industry roles, and the journey of scientific discoveries from the lab to real-world impact, including regulatory and funding challenges. 🌐 Learn more and register. ➡️ https://lnkd.in/eDkkT5_4
Our sponsors play an important role in making the #MbDsymposium a success. A big thank you to the many companies and organizations in the #regenmed and #lifesciences ecosystem that are sponsoring the 9th annual #MedicinebyDesign symposium, "Driving translation with transformative science." Learn more ➡ https://lnkd.in/gGZwizpG. CCRM, Stem Cell Network, Innovative Medicines Canada - Médicaments novateurs Canada, Roche Canada, adMare BioInnovations, STEMCELL Technologies, Lumira Ventures, Cytek Biosciences, Vivo Surgery, OBIO, TIAP - Toronto Innovation Acceleration Partners, Life Sciences Ontario, Reactome and BlueRock Therapeutics.
Medicine by Design - University of Toronto reposted this
Are you part of a #regenmed or #PrecisionMedicine research lab at #UofT or its affiliated hospitals? Are you thinking about taking your first steps toward entrepreneurship? Join us on November 21 for an information session on the Building a Biotech Venture program. Learn more and register here: https://lnkd.in/g-NgbbUR
It's #DiabetesAwarenessMonth, and #regenmed strategies for treating diabetes will be a focus at our 9th annual #MbDsymposium. Register now to learn more about how advanced therapies will transform the future of diabetes care: https://lnkd.in/gGZwizpG
Looking forward to an insightful panel discussion on Dec. 9 at the #MbDsymposium, focusing on how platform technologies such as #AI, #CRISPR, #genomeengineering, #synbio are accelerating our understanding of disease biology & informing breakthroughs in #regenmed, #cellandgenetherapy & other advanced therapies. Save your spot today! https://lnkd.in/gGZwizpG This session is sponsored by Lumira Ventures